Items where authors include "Goutman, S.A."

Article

Benatar, M. orcid.org/0000-0003-4241-5135, Heiman-Patterson, T.D. orcid.org/0000-0002-9910-1041, Cooper-Knock, J. orcid.org/0000-0002-0873-8689 et al. (12 more authors) (2024) Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD. Journal of Neurology, Neurosurgery and Psychiatry, 96 (3). pp. 209-218. ISSN 0022-3050

Saez-Atienzar, S., Souza, C.D.S., Chia, R. et al. (323 more authors) (2024) Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data. Cell Genomics, 4 (11). 100679. ISSN 2666-979X

Feldman, E.L. orcid.org/0000-0002-9162-2694, Goutman, S.A. orcid.org/0000-0001-8780-6637, Petri, S. orcid.org/0000-0002-9783-8584 et al. (4 more authors) (2022) Amyotrophic lateral sclerosis. The Lancet, 400 (10360). pp. 1363-1380. ISSN 0140-6736

Gilley, J., Jackson, O., Pipis, M. et al. (19 more authors) (2021) Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders. eLife, 10. e70905. ISSN 2050-084X

Dewan, R. orcid.org/0000-0002-7611-7032, Chia, R. orcid.org/0000-0002-4709-7423, Ding, J. et al. (469 more authors) (2021) Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis. Neuron, 109 (3). 448-460.e4. ISSN 0896-6273